Ovid Therapeutics Inc.
Developing targeted small molecule therapies for rare neurological diseases and epilepsies.
OVID | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6904691010
- LEI:
- Country:
- United States of America
- Address:
- 441 NINTH AVENUE, 14TH FLOOR, 10001 NEW YORK
- Website:
- https://ovidrx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Ovid Therapeutics Inc. is a biopharmaceutical company dedicated to developing impactful medicines for patients and families affected by rare neurological diseases. The company focuses on conquering epilepsies and brain conditions through the development of a new generation of targeted small molecule therapies. Its science-driven, patient-focused mission is to pioneer effective new treatments that reduce seizures and offer improved safety and tolerability. Ovid Therapeutics leverages compounds with unique or potential best-in-class mechanisms of action to create new possibilities for those living with these conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ovid Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ovid Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ovid Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
